Edgewise Therapeutics, Inc.

NASDAQ (USD): Edgewise Therapeutics, Inc. (EWTX)

Last Price

35.20

Today's Change

-0.13 (0.36%)

Day's Change

34.11 - 35.98

Trading Volume

782,329

Overview

Market Cap

3 Billion

Shares Outstanding

94 Million

Avg Volume

1,173,631

Avg Price (50 Days)

28.28

Avg Price (200 Days)

20.57

PE Ratio

-23.01

EPS

-1.53

Earnings Announcement

20-Feb-2025

Previous Close

35.33

Open

35.24

Day's Range

34.11 - 35.985

Year Range

5.93 - 38.12

Trading Volume

782,329

Price Change Highlight

1 Day Change

-0.37%

5 Day Change

-4.22%

1 Month Change

10.28%

3 Month Change

106.45%

6 Month Change

92.03%

Ytd Change

220.00%

1 Year Change

474.23%

3 Year Change

83.24%

5 Year Change

17.33%

10 Year Change

17.33%

Max Change

17.33%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial. It develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment